APA (7th ed.) Citation

KK, M., S, Z., J, C., Z, M., O, E., AT, D., . . . MR, P. (2023). Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms. Antioxidants (Basel, Switzerland), 12(3), . https://doi.org/10.3390/antiox12030595

Chicago Style (17th ed.) Citation

KK, Mak, Zhang S, Chellian J, Mohd Z, Epemolu O, Dinkova-Kostova AT, Balijepalli MK, and Pichika MR. "Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms." Antioxidants (Basel, Switzerland) 12, no. 3 (2023). https://doi.org/10.3390/antiox12030595.

MLA (9th ed.) Citation

KK, Mak, et al. "Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms." Antioxidants (Basel, Switzerland), vol. 12, no. 3, 2023, https://doi.org/10.3390/antiox12030595.